| CAT No: | CL-INF-001 |
| CAS No: | 872511-34-7 |
| Mol.F: | C26H31Cl2N7O3 |
| Mol.Wt.: | 560.5 |
| Chemical Name: | 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea |
| Inventory Status: | Custom synthesis |
This impurity is related to Infigratinib is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Infigratinib is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylureaCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Infigratinib Molecular Formula: C26H31Cl2N7O3
Molecular Weight: 560.5
Storage: Store in a cool, dry place.
| Product Name: | Infigratinib |
| CAS No: | 872511-34-7 |
| Mol.F.: | C26H31Cl2N7O3 |
| Mol.Wt.: | 560.5 |
Cat. No: CL-INF-NO-01
CAS No: NA
Mol. F: C26H30CL2N8O4
Mol. Wt: 589.48
Inv. Status: Custom Synthesis
Cat. No: CL-INF-NO-02
CAS No: NA
Mol. F: C25H28CL2N8O4
Mol. Wt: 589.48
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: